NCT04932668

Brief Summary

Spasticity is a common complication post stroke. Post-stroke spasticity along with weakness and lack of coordination result in gait abnormalities and functional limitations. Recent treatment option include neuromuscular electric stimulation (NMES), a form of therapy that applies electrical currents to produce contraction of innervated muscle by depolarizing local motor nerves. Currently, there are wide varieties of NMES devices available commercially for consumer. The main purpose of this study is to evaluate the feasibility and acceptability of a home-based NMES program on lower limb spasticity in patient with post-stroke more than 6 months and to assess the impact of the program. This is single arm prospective intervention study. Patient will apply home-based NMES on their leg for 20 minutes, 5 days a week for 4 weeks. At the end of the study, an outcome measures will be assessed and patient will be required to answer a questionnaires on their experience.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 5, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 6, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 21, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2022

Completed
Last Updated

June 21, 2021

Status Verified

June 1, 2021

Enrollment Period

9 months

First QC Date

June 6, 2021

Last Update Submit

June 12, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Retention Rate

    The proportion of patients who completed the program. Patient completed divided with patient recruited, expressed in percentage (%).

    4 weeks

  • Acceptability

    Acceptability as evaluated at the end of the intervention by brief structured questionnaire developed for this study using 5 point Likert scale with 1 (strongly agree) and 5 (strongly agree).

    4 weeks

Secondary Outcomes (4)

  • Clinical measurement of spasticity

    4 weeks (pre and post assessment)

  • Clinical measurement of spasticity

    4 weeks (pre and post assessment)

  • Ankle dorsiflexion muscle strength

    4 weeks (pre and post assessment)

  • Functional Outcome

    4 weeks (pre and post assessment)

Study Arms (1)

Home-based Electrical Stimulation Program for lower limb spasticity

EXPERIMENTAL

Single arm prospective intervention study to assess the feasibility and impact of a home-based program. Patient will apply home-based NMES on their leg for 20 minutes, 5 days a week for 4 weeks. At the end of the study, an outcome measures will be assessed and patient will be required to answer a questionnaires on their experience.

Other: Feasibility and Impact of Home-based Electrical Stimulation Program

Interventions

Home-based NMES program on spastic leg. The NMES pre-programmed dosage (locked): NMES waveform is biphasic PC, Frequency 50Hz, pulse width 400µs, ON:OFF 10s:20s and current amplitude: individual maximum tolerated to achieve ankle dorsiflexion.

Also known as: Program
Home-based Electrical Stimulation Program for lower limb spasticity

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Post stroke (hemorrhagic or ischemic) with ankle plantarflexor (gastrocnemius and soleus) spasticity MAS 1+ to MAS 3,
  • Post stroke more than 6 months,
  • At least 18 years old,
  • Able to ambulate 10 meter either independently or aided (single point stick or quadripod)
  • Compliant to outpatient therapy.
  • Minimal cognitive (MMSE\> 24) and minimal sensory impairment,
  • Stable neurological and medical condition

You may not qualify if:

  • Introduction or changes in anti-spastic medication dose within 3 months or during study period,
  • Receiving intervention for spasticity (eg BoNT or serial casting) within 3 months or during research period,
  • New neurological condition/disease,
  • Presence of contraindications to NMES, which is: Pregnancy, Malignancy, Presence of electronic implant eg cardiac pacemaker, cardioverter defibrillator, Uncontrolled seizure/epilepsy, Infected tissues/ tuberculosis or osteomyelitis, Impaired lower limb circulation/ DVT/ thrombophlebitis, Recent fracture or osteoporosis, Actively bleeding tissue or person with untreated hemorrhagic disorder, Damaged or skin diseases at the affected lower limb

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Malaya Medical Center

Kuala Lumpur, 59100, Malaysia

RECRUITING

Study Officials

  • Raja Nabila BT Raja Mohamed Anuar

    University Malaya Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tze Yang Chung

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: To evaluate the feasibility and acceptability of a home-based NMES program on lower limb spasticity in patient with post-stroke
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor, Principal Investigator

Study Record Dates

First Submitted

June 6, 2021

First Posted

June 21, 2021

Study Start

November 5, 2020

Primary Completion

August 1, 2021

Study Completion

February 1, 2022

Last Updated

June 21, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations